Enalapril Orodispersible Minitablet

DRUG3 trials

Sponsors

Ethicare GmbH

Conditions

Congenital Heart DiseaseDilated CardiomyopathyHeart Failure

Phase 2

Orodispersible Minitablets of Enalapril in Children With Heart Failure Due to Dilated Cardiomyopathy

Ethicare GmbHDilated Cardiomyopathy, Heart Failure

Start: 2016-01-31End: 2017-06-30Target: 50Updated: 2016-01-12

Orodispersible Minitablets of Enalapril in Young Children With Heart Failure Due to Congenital Heart Disease

Ethicare GmbHCongenital Heart Disease, Heart Failure

Start: 2016-01-31End: 2017-06-30Target: 50Updated: 2016-01-12

Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril

Ethicare GmbHCongenital Heart Disease, Dilated Cardiomyopathy, Heart Failure

Start: 2016-03-31End: 2018-04-30Target: 100Updated: 2016-01-13